Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

[1]  D. Bauer,et al.  Sex hormones and the risk of incident prostate cancer. , 2010, Urology.

[2]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[3]  G. Risbridger,et al.  Aromatase and regulating the estrogen:androgen ratio in the prostate gland , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  Li Yang,et al.  Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis , 2009, Journal of experimental & clinical cancer research : CR.

[5]  I. Thompson,et al.  Alcohol consumption, finasteride, and prostate cancer risk , 2009, Cancer.

[6]  L. Marks.  Words of wisdom. Re: Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. , 2009, European urology.

[7]  G. Risbridger,et al.  The Dual, Opposing Roles of Estrogen in the Prostate , 2009, Annals of the New York Academy of Sciences.

[8]  I. Thompson,et al.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. , 2008, American journal of epidemiology.

[9]  A. Whittemore,et al.  Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States) , 2006, Cancer Causes & Control.

[10]  I. Thompson,et al.  Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial , 2006, Cancer Epidemiology Biomarkers & Prevention.

[11]  D. English,et al.  Circulating Steroid Hormones and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[12]  W. Willett,et al.  Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era , 2005, Cancer Epidemiology Biomarkers & Prevention.

[13]  J. F. Schmitt,et al.  Local aromatase expression in human prostate is altered in malignancy. , 2004, The Journal of clinical endocrinology and metabolism.

[14]  S. Ho.  Estrogens and anti‐estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates , 2004, Journal of cellular biochemistry.

[15]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[16]  Ruth Etzioni,et al.  Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  Michael M Lieber,et al.  Journal Review , 2003, International Society of Hair Restoration Surgery.

[18]  E. Baulieu.  Androgens and aging men , 2002, Molecular and Cellular Endocrinology.

[19]  J. Kaufman,et al.  Estradiol in elderly men , 2002, The aging male : the official journal of the International Society for the Study of the Aging Male.

[20]  Hong Wang,et al.  Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. , 2001, Endocrinology.

[21]  L. Kalish,et al.  Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study. , 2001, Urology.

[22]  C. Mantzoros,et al.  Hormonal predictors of prostate cancer: a meta-analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  T. Key,et al.  Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies , 1999, British Journal of Cancer.

[24]  D. Albanes,et al.  Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  M. Stampfer,et al.  Prospective study of sex hormone levels and risk of prostate cancer. , 1996, Journal of the National Cancer Institute.

[26]  M. Bosland,et al.  Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. , 1995, Carcinogenesis.

[27]  R. Nass,et al.  Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. , 1993, The Journal of clinical endocrinology and metabolism.

[28]  A. Hsing,et al.  Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  E. Barrett-Connor,et al.  A prospective, population-based study of androstenedione, estrogens, and prostatic cancer. , 1990, Cancer research.

[30]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[31]  G. Stemmermann,et al.  Prediagnostic serum hormones and the risk of prostate cancer. , 1988, Cancer research.

[32]  A. V. Landeghem,et al.  Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. , 1985, Cancer research.